Results 181 to 190 of about 759,550 (222)

Real-world effectiveness and safety of adebrelimab as first-line treatment in patients with extensive-stage small cell lung cancer. [PDF]

open access: yesTransl Lung Cancer Res
Lv T   +18 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Methodological clarifications on maintenance fluoropyrimidines in advanced esophagogastric adenocarcinoma: a real-world Mexican cohort. [PDF]

open access: yesJ Gastrointest Oncol
Dip Borunda AK   +6 more
europepmc   +1 more source

Biweekly carboplatin plus nab-paclitaxel with concurrent radiotherapy followed by durvalumab consolidation for unresectable locally advanced non-small cell lung cancer: a real-world retrospective cohort study. [PDF]

open access: yesTransl Lung Cancer Res
Nunomura Y   +14 more
europepmc   +1 more source

Utidelone exhibits favorable responses in refractory patients with advanced breast cancer. [PDF]

open access: yesTransl Cancer Res
Bai X   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy